Literature DB >> 7653685

Psychotherapy in community methadone programs: a validation study.

G E Woody1, A T McLellan, L Luborsky, C P O'Brien.   

Abstract

OBJECTIVE: The authors tested the efficacy of individual psychotherapy in the rehabilitation counseling of psychiatrically symptomatic opiate-dependent patients during methadone maintenance treatment in community programs.
METHOD: Volunteers in three community programs were randomly assigned to 24 weeks of counseling plus supplemental drug counseling or to counseling plus supportive-expressive psychotherapy. Follow-ups were done 1 and 6 months after treatment ended. A total of 84 subjects were evaluated at both follow-up points.
RESULTS: During the study the patients receiving supportive-expressive psychotherapy and those receiving drug counseling had similar proportions of opiate-positive urine samples, but the patients receiving supportive-expressive psychotherapy had fewer cocaine-positive urine samples and required lower doses of methadone. One month after the extra therapy ended both groups had made significant gains, but there were no significant differences between groups. By 6-month follow-up many of the gains made by the drug counseling patients had diminished, whereas most of the gains made by the patients who received supportive-expressive psychotherapy remained or were still evident; many significant differences emerged, all favoring supportive-expressive psychotherapy.
CONCLUSIONS: Psychotherapy can be delivered to psychiatrically impaired patients in community methadone programs. Additional counseling is associated with early benefits comparable to those from psychotherapy, but these gains are not sustained. The gains associated with psychotherapy persist and in some cases strengthen for at least 6 months after the end of therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7653685     DOI: 10.1176/ajp.152.9.1302

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  21 in total

Review 1.  Evidence-based practices for substance use disorders.

Authors:  Mark P McGovern; Kathleen M Carroll
Journal:  Psychiatr Clin North Am       Date:  2003-12

Review 2.  The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence.

Authors:  Steven Simoens; Catriona Matheson; Christine Bond; Karen Inkster; Anne Ludbrook
Journal:  Br J Gen Pract       Date:  2005-02       Impact factor: 5.386

3.  Psychoanalysis today.

Authors:  Peter Fonagy
Journal:  World Psychiatry       Date:  2003-06       Impact factor: 49.548

4.  Therapist interventions in early sessions of brief supportive-expressive psychotherapy for depression.

Authors:  M B Connolly; P Crits-Christoph; S Shappell; J P Barber; L Luborsky
Journal:  J Psychother Pract Res       Date:  1998

5.  The effectiveness of psychodynamic psychotherapies: An update.

Authors:  Peter Fonagy
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

6.  Profiting and providing less care: comprehensive services at for-profit, nonprofit, and public opioid treatment programs in the United States.

Authors:  Marcus A Bachhuber; William N Southern; Chinazo O Cunningham
Journal:  Med Care       Date:  2014-05       Impact factor: 2.983

7.  Counseling and directly observed medication for primary care buprenorphine maintenance: a pilot study.

Authors:  Brent A Moore; Declan T Barry; Lynn E Sullivan; Patrick G Oʼconnor; Christopher J Cutter; Richard S Schottenfeld; David A Fiellin
Journal:  J Addict Med       Date:  2012-09       Impact factor: 3.702

8.  A pilot open trial of brief psychodynamic psychotherapy for panic disorder.

Authors:  B Milrod; F Busch; A C Leon; A Aronson; J Roiphe; M Rudden; M Singer; T Shapiro; H Goldman; D Richter; M K Shear
Journal:  J Psychother Pract Res       Date:  2001

Review 9.  Penn/VA center for studies of addiction.

Authors:  Charles P O'Brien; A Thomas McLellan; Anna Rose Childress; George E Woody
Journal:  Neuropharmacology       Date:  2008-06-26       Impact factor: 5.250

Review 10.  Using behavioral reinforcement to improve methadone treatment participation.

Authors:  Robert K Brooner; Michael Kidorf
Journal:  Sci Pract Perspect       Date:  2002-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.